About your Search

20120925
20121003
Search Results 0 to 3 of about 4
. the science writer and columnist for discover magazine will look at the cyberworld popular culture and computer networking and politics. lives in their october 7 at noon eastern on c-span2 book tv. up next, a debate between kendis to be the next governor of new hampshire. the republican candidates unsuccessfully ran for governor in 1996 and was the republican nominee for the u.s. senate in 2010. democrat is a former new hampshire state senator who served as the majority leader. this took place in manchester, new hampshire and comes to us from new hampshire public broadcasting and is about an hour. >> welcome to the candidates' forum on business and the economy. i am most of the exchange. we are coming to you from the television studios at the new hampshire is to to the politics that political library. for the next hour we will hear from new hampshire is gubernatorial candidates. we will press them to talk about what they would do as governor and refrain from spending valuable time attacking each other. and now let me introduce our candid it's. they are republican ovide lamontagne a
holding businesses responsible. >> in the light jacket. >> hi, i co-chaired the defense science energy security task force with jim schlesinger and i currently just been named the technical cochairman of the chief of naval operations vulnerability on energy security and i would like to talk about, first of i like to take the opportunity say that, the states and ferc on electricity and energy regulation, the states regulate almost exclusively for rate, rates, not for reliability at all. and ferc regulations are, they can take effect after a process that takes four to six years. in light of the rate of threat which is something else i wanted to talk about, we have no effective regulatory system. so i'm particularly concerned about sif and particularly concerned about cyber and i, i would like to call into question the perishability of cyber solutions. the lot of the discussion today, which i completely agree with all of it, focused on the cyber solutions to the cyber problems but i would like to point out that because of the rate of the threat, particularly with the bad actors, we might
before, is a science and technology, not for profit policy think tank, if you will for the washington, d.c., area that focuses on how science and technology affects our national security. for quite some time, we have been involved in the study of issues in and around what people call acementic threats. and most importantly terrorism. this past year, professor al sander an i realize released our second volume on al qaeda about the first volume on al qaeda right before 9/11. i would like to call your attention to it. there are copies available here and on the web and amazon. all the good things. i want to highlight it today. it's one of the gifts we are going to give to the members for takes the time out of their busy schedule to join us today. i can patrol you a good sleep if you read it. [laughter] the second work that the institute has been evolved in is the wefort the corporation to look at the cyber issue in particular cyber doctorate. that volume ed kitted by tim and i is in publication as we speak. so you a short flier of that summarizes what is in the volume. it will be out shortly
to actually do something that will be good for patients and good for science going forward so this is the one thing that didn't make it. the other little thick that didn't make it is now the safe dosage act, passed in the last minute, by the senate, and that's awaiting the president's signature, but one of the things that's necessary in terms of the resources is that this has to be a global enterprise. one of the things that is happening globally is the leading pharmaceutical companies in the united states, in europe, in japan have banded together to work with interpol to ensure they have enough resources to go after the bad guys around the world, and we've just started that. i think we're going to kick that off here next month. we've been discussing this with interpol, and we think we have a good program to help country's specific enforcement agencies with the global respective of interpol. yes, it costs money. it is money well spent, but more importantly, it gets us the heart of the trust that patients have to have in our medicines. >> ralph, i know as we've worked on the partnership and bu
Search Results 0 to 3 of about 4